Nadine. Beetz, et.al., Phosducin influences sympathetic activity and prevents stress-induced hypertension in humans and mice., The Journal of clinical investigation, 2009, 119

http://rdf.ncbi.nlm.nih.gov/pubmed/19959875

Nadine. Beetz, et.al., Phosducin influences sympathetic activity and prevents stress-induced hypertension in humans and mice., The Journal of clinical investigation, 2009, 119

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Pdc<tm1Luhe>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4417957

class

http://purl.org/net/cito/citesAsAuthority

• Pdc<tm1Luhe>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4417957

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• abnormal systemic arterial blood pressure_Pdc<tm1Luhe>/Pdc<tm1Luhe>
  http://metadb.riken.jp/0000230B6129P2Pdctm1LuhePdctm1LuhePdctm1LuhePdctm1Luhe
• hypertension_Pdc<tm1Luhe>/Pdc<tm1Luhe>
  http://metadb.riken.jp/0000231B6129P2Pdctm1LuhePdctm1LuhePdctm1LuhePdctm1Luhe
• hypertension_Pdc<tm1Luhe>/Pdc<tm1Luhe>
  http://metadb.riken.jp/0000231I129P2OlaHsdC3HHeNC57BL6JPdctm1LuhePdctm1LuhePdctm1Luhe
• abnormal cardiovascular system physiology_Pdc<tm1Luhe>/Pdc<tm1Luhe>
  http://metadb.riken.jp/0001544B6129P2Pdctm1LuhePdctm1LuhePdctm1LuhePdctm1Luhe
• abnormal cardiovascular system morphology_Pdc<tm1Luhe>/Pdc<tm1Luhe>
  http://metadb.riken.jp/0002127B6129P2Pdctm1LuhePdctm1LuhePdctm1LuhePdctm1Luhe
• mydriasis_Pdc<tm1Luhe>/Pdc<tm1Luhe>
  http://metadb.riken.jp/0002546B6129P2Pdctm1LuhePdctm1LuhePdctm1LuhePdctm1Luhe
他21件を見る
• increased heart rate_Pdc<tm1Luhe>/Pdc<tm1Luhe>
  http://metadb.riken.jp/0002626B6129P2Pdctm1LuhePdctm1LuhePdctm1LuhePdctm1Luhe
• increased systemic arterial blood pressure_Ptgs2<tm1Unc>/Ptgs2<tm1Unc>
  http://metadb.riken.jp/0002842I129P2OlaHsdC57BL6JPtgs2tm1UncPtgs2tm1UncPtgs2tm1Unc
• vascular smooth muscle hypertrophy_Pdc<tm1Luhe>/Pdc<tm1Luhe>
  http://metadb.riken.jp/0002975B6129P2Pdctm1LuhePdctm1LuhePdctm1LuhePdctm1Luhe
• increased vasoconstriction_Pdc<tm1Luhe>/Pdc<tm1Luhe>
  http://metadb.riken.jp/0003025B6129P2Pdctm1LuhePdctm1LuhePdctm1LuhePdctm1Luhe
• abnormal response/metabolism to endogenous compounds_Pdc<tm1Luhe>/Pdc<tm1Luhe>
  http://metadb.riken.jp/0003638B6129P2Pdctm1LuhePdctm1LuhePdctm1LuhePdctm1Luhe
• decreased heart rate_Pdc<tm1Luhe>/Pdc<tm1Luhe>
  http://metadb.riken.jp/0005333B6129P2Pdctm1LuhePdctm1LuhePdctm1LuhePdctm1Luhe
• abnormal action potential_Pdc<tm1Luhe>/Pdc<tm1Luhe>
  http://metadb.riken.jp/0005402B6129P2Pdctm1LuhePdctm1LuhePdctm1LuhePdctm1Luhe
• decreased vasodilation_Pdc<tm1Luhe>/Pdc<tm1Luhe>
  http://metadb.riken.jp/0005591B6129P2Pdctm1LuhePdctm1LuhePdctm1LuhePdctm1Luhe
• increased ventricle muscle contractility_Pdc<tm1Luhe>/Pdc<tm1Luhe>
  http://metadb.riken.jp/0005600B6129P2Pdctm1LuhePdctm1LuhePdctm1LuhePdctm1Luhe
• increased circulating noradrenaline level_Pdc<tm1Luhe>/Pdc<tm1Luhe>
  http://metadb.riken.jp/0005665B6129P2Pdctm1LuhePdctm1LuhePdctm1LuhePdctm1Luhe
• increased systemic arterial diastolic blood pressure_Pdc<tm1Luhe>/Pdc<tm1Luhe>
  http://metadb.riken.jp/0006143B6129P2Pdctm1LuhePdctm1LuhePdctm1LuhePdctm1Luhe
• increased systemic arterial diastolic blood pressure_Pdc<tm1Luhe>/Pdc<tm1Luhe>
  http://metadb.riken.jp/0006143I129P2OlaHsdC3HHeNC57BL6JPdctm1LuhePdctm1LuhePdctm1Luhe
• increased systemic arterial diastolic blood pressure_Ptgs2<tm1Unc>/Ptgs2<tm1Unc>
  http://metadb.riken.jp/0006143I129P2OlaHsdC57BL6JPtgs2tm1UncPtgs2tm1UncPtgs2tm1Unc
• increased systemic arterial systolic blood pressure_Pdc<tm1Luhe>/Pdc<tm1Luhe>
  http://metadb.riken.jp/0006144B6129P2Pdctm1LuhePdctm1LuhePdctm1LuhePdctm1Luhe
• increased systemic arterial systolic blood pressure_Pdc<tm1Luhe>/Pdc<tm1Luhe>
  http://metadb.riken.jp/0006144I129P2OlaHsdC3HHeNC57BL6JPdctm1LuhePdctm1LuhePdctm1Luhe
• increased systemic arterial systolic blood pressure_Ptgs2<tm1Unc>/Ptgs2<+>
  http://metadb.riken.jp/0006144I129P2OlaHsdC57BL6JPtgs2tm1UncPtgs2Ptgs2tm1UncPtgs2
• increased systemic arterial systolic blood pressure_Ptgs2<tm1Unc>/Ptgs2<tm1Unc>
  http://metadb.riken.jp/0006144I129P2OlaHsdC57BL6JPtgs2tm1UncPtgs2tm1UncPtgs2tm1Unc
• decreased systemic arterial systolic blood pressure_Pdc<tm1Luhe>/Pdc<tm1Luhe>
  http://metadb.riken.jp/0006264B6129P2Pdctm1LuhePdctm1LuhePdctm1LuhePdctm1Luhe
• increased heart ventricle size_Pdc<tm1Luhe>/Pdc<tm1Luhe>
  http://metadb.riken.jp/0008772B6129P2Pdctm1LuhePdctm1LuhePdctm1LuhePdctm1Luhe
• increased physiological sensitivity to xenobiotic_Pdc<tm1Luhe>/Pdc<tm1Luhe>
  http://metadb.riken.jp/0008873B6129P2Pdctm1LuhePdctm1LuhePdctm1LuhePdctm1Luhe
• abnormal urine catecholamine level_Pdc<tm1Luhe>/Pdc<tm1Luhe>
  http://metadb.riken.jp/0011478B6129P2Pdctm1LuhePdctm1LuhePdctm1LuhePdctm1Luhe

トランスクリプトームデータ

http://rdf.ncbi.nlm.nih.gov/pubmed/

• CD39694
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD39694